Rauh-Hain JA - Search Results

1

Trends in the use of neoadjuvant chemotherapy for advanced ovarian cancer in the United States.

Melamed A, Hinchcliff EM, Clemmer JT, Bregar AJ, Uppal S, Bostock I, Schorge JO, Del Carmen MG, Rauh-Hain JA. Melamed A, et al. Gynecol Oncol. 2016 Nov;143(2):236-240. doi: 10.1016/j.ygyno.2016.09.002. Epub 2016 Sep 6. Gynecol Oncol. 2016. PMID: 27612977

2

Potential benefit of Sunitinib in recurrent and refractory ovarian clear cell adenocarcinoma.

Rauh-Hain JA, Penson RT. Rauh-Hain JA, et al. Int J Gynecol Cancer. 2008 Sep-Oct;18(5):934-6. doi: 10.1111/j.1525-1438.2007.01156.x. Epub 2007 Dec 13. Int J Gynecol Cancer. 2008. PMID: 18081793

3

Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma.

Olawaiye AB, Rauh-Hain JA, Withiam-Leitch M, Rueda B, Goodman A, del Carmen MG. Olawaiye AB, et al. Gynecol Oncol. 2008 Sep;110(3):293-8. doi: 10.1016/j.ygyno.2008.05.027. Epub 2008 Jul 21. Gynecol Oncol. 2008. PMID: 18644620

4

HPV vaccine: A comparison of attitudes and behavioral perspectives between Latino and non-Latino women.

Watts LA, Joseph N, Wallace M, Rauh-Hain JA, Muzikansky A, Growdon WB, del Carmen MG. Watts LA, et al. Gynecol Oncol. 2009 Mar;112(3):577-82. doi: 10.1016/j.ygyno.2008.12.010. Epub 2009 Jan 15. Gynecol Oncol. 2009. PMID: 19150120

5

Understanding barriers to cervical cancer screening among Hispanic women.

Watts L, Joseph N, Velazquez A, Gonzalez M, Munro E, Muzikansky A, Rauh-Hain JA, Del Carmen MG. Watts L, et al. Am J Obstet Gynecol. 2009 Aug;201(2):199.e1-8. doi: 10.1016/j.ajog.2009.05.014. Am J Obstet Gynecol. 2009. PMID: 19646571

6

Impact of bowel obstruction at the time of initial presentation in women with ovarian cancer.

Rauh-Hain JA, del Carmen M, Horowitz NS, Alarcon IA, Ko E, Goodman AK, Olawaiye AB. Rauh-Hain JA, et al. BJOG. 2010 Jan;117(1):32-8. doi: 10.1111/j.1471-0528.2009.02416.x. BJOG. 2010. PMID: 20002368

7

Role of computed tomography in the surgical management of patients with bowel obstruction secondary to recurrent ovarian carcinoma.

Rauh-Hain JA, Olawaiye AB, Munro M, Ko E, Alarcon IA, Del Carmen MG, Duska L. Rauh-Hain JA, et al. Ann Surg Oncol. 2010 Mar;17(3):853-60. doi: 10.1245/s10434-009-0813-x. Ann Surg Oncol. 2010. PMID: 20183913

8

Treatment for advanced and recurrent endometrial carcinoma: combined modalities.

Rauh-Hain JA, Del Carmen MG. Rauh-Hain JA, et al. Oncologist. 2010;15(8):852-61. doi: 10.1634/theoncologist.2010-0091. Epub 2010 Jul 21. Oncologist. 2010. PMID: 20660059 Free PMC article. Review.

9

Prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma.

Rauh-Hain JA, Growdon WB, Schorge JO, Goodman AK, Boruta DM, McCann C, Horowitz NS, del Carmen MG. Rauh-Hain JA, et al. Gynecol Oncol. 2010 Nov;119(2):299-304. doi: 10.1016/j.ygyno.2010.07.010. Epub 2010 Aug 5. Gynecol Oncol. 2010. PMID: 20691465

10

A comparison of outcome in patients with stage 1 clear cell and grade 3 endometrioid adenocarcinoma of the endometrium with and without adjuvant therapy.

Rauh-Hain JA, Costaaggini I, Olawaiye AB, Growdon WB, Horowitz NS, del Carmen MG. Rauh-Hain JA, et al. Eur J Gynaecol Oncol. 2010;31(3):284-7. Eur J Gynaecol Oncol. 2010. PMID: 21077469

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters